Greener Alternative Product - Portfolio
More sustainable lab products for responsible science
Topics
Request information
Greener Alternative Product - Portfolio
More sustainable lab products for responsible science
More videos from Merck
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Trade-fair analytica
Here, innovative exhibitors present their trade fair innovations, premieres and product innovations for analytica 2026.
Trade-fair analytica
Here, innovative exhibitors present their trade fair innovations, premieres and product innovations for analytica 2026.
More videos on similar topics
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Last viewed contents
Getting the Full Picture: Predicting the Aggregation Propensity of mAbs - Fully Automated Chemical and Thermal Denaturation Study Predicts Long-Term Stability in Formulations
Predicting the Long-Term Stability of Biologics - Analysis of Formulation-Dependent Colloidal and Conformational Stability of Monoclonal Antibodies
Verifying SPARCL Performance on the CLARIOstar Equipped for Reading at Time of Injection -
Optimizing Protein Purification Conditions -
Streamlining Affinity Analysis for Accelerated Biologics Development and Production - High-throughput and assay versatility for rapid development and qualification of biopharmaceuticals
Optimizing Kinetics Assays to Prevent Avidity Effects - Robust experimental design avoids artefacts in the measurement of binding kinetics and affinity
Now ready - Easy Bispecific Antibody Evaluation - Analyze specific binding of bsAbs in addition to IgG titer in a single high-throughput assay
How to purify and analyze your antibodies efficiently - All the chromatography methods and practical tips to simplify and reduce the costs of your processes
Advance Lot Release and In-process Testing of Biologics in QC - Comprehensive technical and service support for Octet® users in GxP environments
Billion-Dollar Deal for Cancer Antibody: BioNTech and Bristol Myers Squibb Join Forces - "...an asset with significant potential for transforming the standard of care for patients with solid tumors"
Structural basis of the function of therapeutic antibodies in cancer immunotherapy elucidated - New study shows how the single-molecule organization of receptors in the cellular context determines the function of antibodies




















